Addex Therapeutics Ltd (SWX:ADXN)
0.0650
+0.0046 (7.62%)
Sep 30, 2025, 5:31 PM CET
Addex Therapeutics Revenue
Addex Therapeutics had revenue of 71.06K CHF in the quarter ending March 31, 2025, a decrease of -69.75%. This brings the company's revenue in the last twelve months to 246.19K, down -81.76% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.
Revenue (ttm)
246.19K
Revenue Growth
-81.76%
P/S Ratio
35.51
Revenue / Employee
83.64K
Employees
2
Market Cap
5.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 410.04K | -1.21M | -74.64% |
Dec 31, 2023 | 1.62M | 172.23K | 11.92% |
Dec 31, 2022 | 1.44M | -1.71M | -54.18% |
Dec 31, 2021 | 3.15M | -725.84K | -18.71% |
Dec 31, 2020 | 3.88M | 1.05M | 36.89% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Novartis AG | 43.89B |
Lonza Group AG | 7.09B |
Galderma Group AG | 3.73B |
Alcon | 7.97B |
Sandoz Group AG | 8.42B |
Straumann Holding AG | 2.58B |
Sonova Holding AG | 3.87B |
Addex Therapeutics News
- 21 hours ago - Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 days ago - Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025 - GlobeNewsWire
- 7 days ago - Addex Appoints Bank of New York Mellon as Depositary Bank - GlobeNewsWire
- 18 days ago - Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga
- 4 weeks ago - Earnings Scheduled For September 1, 2025 - Benzinga
- 3 months ago - Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs - GlobeNewsWire
- 3 months ago - Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders - GlobeNewsWire
- 3 months ago - Addex Shareholders Approve All Resolutions at Annual General Meeting - GlobeNewsWire